Bristol-Myers Squibb Company ( BMY) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 1.4%. By the end of trading, Bristol-Myers Squibb Company rose 32 cents (0.9%) to $34.29 on average volume. Throughout the day, 7.5 million shares of Bristol-Myers Squibb Company exchanged hands as compared to its average daily volume of 9.8 million shares. The stock ranged in a price between $34.10-$34.31 after having opened the day at $34.12 as compared to the previous trading day's close of $33.97. Other companies within the Health Care sector that increased today were: Medgenics ( MDGN), up 23.5%, Amyris ( AMRS), up 19.2%, Kindred Healthcare ( KND), up 18.8%, and Accelr8 Technology Corporation ( AXK), up 18.1%. Bristol-Myers Squibb Company, a biopharmaceutical company, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products that help patients prevail over serious diseases worldwide. Bristol-Myers Squibb Company has a market cap of $57.27 billion and is part of the drugs industry. The company has a P/E ratio of 15.7, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are down 3.7% year to date as of the close of trading on Tuesday. Currently there are 11 analysts that rate Bristol-Myers Squibb Company a buy, one analyst rates it a sell, and nine rate it a hold. TheStreet Ratings rates Bristol-Myers Squibb Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow.
- You can view the full Bristol-Myers Squibb Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.